Trial Profile
A first-in-human, pharmacokinetic and tolerability study of LFF 571 at single and multiple doses in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Oct 2012
Price :
$35
*
At a glance
- Drugs LFF 571 (Primary)
- Indications Clostridium difficile infections
- Focus Adverse reactions; First in man; Pharmacokinetics
- 27 Sep 2011 New trial record
- 20 Sep 2011 Results presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy.